By Malcolm Stacey | Tuesday 9 March 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Chompers. One of the more difficult sectors to call on this august website is in the covid-testing game. Of course, there are loads of aspirants to the title of being a good tester, but perhaps Avacta (AVCT) is the most covered. It certainly attracts a disproportionate number of posters on other websites, some of whom are in the hopeless optimist category…